If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

Despite substantial progress towards achieving the UNAIDS 95–95–95 targets,1 the global HIV response continues to be undermined by a multitude of complex, interrelated challenges. Persistent stigma ...

A new modelling study has sought to find out what impact recent foreign aid cuts – particularly from the US – will have on ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

Research programs that would help make the HIV response more effective and affordable have been slashed. This will make it more difficult for officials as they look to guide the response forward ...

Human immunodeficiency virus, or HIV, is a virus that attacks the body’s immune system and it can lead to acquired immunodeficiency syndrome (AIDS). Currently, while there is no cure for HIV ...

They're not a cure for HIV. These medicines aim to: Control the growth of the virus Improve how well your immune system works Slow or stop symptoms Prevent transmission of HIV to others By taking ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet, external medical journal.

Toronto Public Health has sent letters to around 2,500 patients, notifying them of potential exposure to HIV, hepatitis B, and hepatitis C due to an infection control breach at a Toronto ...

As virus experts, we’re committed to research that uncovers pandemic threats and helps protect people from them. But we are concerned about how some scientists are experimenting with viruses in ...